{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:47:09Z","timestamp":1789051629272,"version":"build-2803163510"},"reference-count":78,"publisher":"Tsinghua University Press","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.26599\/1671-5411.2024.11.005","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T08:51:04Z","timestamp":1735807864000},"page":"1085-1095","source":"Crossref","is-referenced-by-count":9,"title":["The role of acetazolamide in critical care and emergency medicine"],"prefix":"10.26599","volume":"21","author":[{"given":"Jacopo Davide","family":"Giamello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Savioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaroslava","family":"Longhitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorenza","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"D\u2019Agnano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfredi","family":"Tesauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Zanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11138","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2291336","DOI":"10.1080\/14756366.2023.2291336","article-title":"Acetazolamide and human carbonic anhydrases: retrospect, review and discussion of an intimate relationship","volume":"39","author":"D Tsikas","year":"2024","unstructured":"D Tsikas. Acetazolamide and human carbonic anhydrases: retrospect, review and discussion of an intimate relationship. 2024, 39: 2291336.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.4155\/fmc-2021-0222","article-title":"Novel carbonic anhydrase inhibitors","volume":"13","author":"CT Supuran","year":"2021","unstructured":"CT Supuran. Novel carbonic anhydrase inhibitors. 2021, 13: 1935-1937.","journal-title":"Future Med Chem"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"112923","DOI":"10.1016\/j.ejmech.2020.112923","article-title":"Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors","volume":"209","author":"S Kumar","year":"2021","unstructured":"S Kumar. Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors. 2021, 209: 112923.","journal-title":"Eur J Med Chem"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/med.10025","article-title":"Carbonic anhydrase inhibitors","volume":"23","author":"CT Supuran","year":"2003","unstructured":"CT Supuran. Carbonic anhydrase inhibitors. 2003, 23: 146-189.","journal-title":"Med Res Rev"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1080\/13543776.2018.1523897","article-title":"Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas","volume":"28","author":"CT Supuran","year":"2018","unstructured":"CT Supuran. Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas. 2018, 28: 709-712.","journal-title":"Expert Opin Ther Pat"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1042\/CS20210040","article-title":"Emerging role of carbonic anhydrase inhibitors","volume":"135","author":"CT Supuran","year":"2021","unstructured":"CT Supuran. Emerging role of carbonic anhydrase inhibitors. 2021, 135: 1233-1249.","journal-title":"Clin Sci (Lond)"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"7315","DOI":"10.3390\/curroncol30080531","article-title":"Acute Oncologic Complications: Clinical-Therapeutic Management in Critical Care and Emergency Departments","volume":"30","author":"N Gri","year":"2023","unstructured":"N Gri. Acute Oncologic Complications: Clinical-Therapeutic Management in Critical Care and Emergency Departments. 2023, 30: 7315-7334.","journal-title":"Curr Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"BA Bart","year":"2012","unstructured":"BA Bart. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. 2012, 367: 2296-2304.","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000615","author":"","unstructured":"","journal-title":"null"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","article-title":"Acetazolamide in Acute Decompensated Heart Failure with Volume Overload","volume":"387","author":"W Mullens","year":"2022","unstructured":"W Mullens. Acetazolamide in Acute Decompensated Heart Failure with Volume Overload. 2022, 387: 1185-1195.","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1093\/eurheartj\/ehad557","article-title":"Renal function and decongestion with acetazolamide in acute decompensated heart failure: the ADVOR trial","volume":"44","author":"E Meekers","year":"2023","unstructured":"E Meekers. Renal function and decongestion with acetazolamide in acute decompensated heart failure: the ADVOR trial. 2023, 44: 3672-3682.","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s11739-020-02422-z","article-title":"Novel biomarkers to assess the risk for acute coronary syndrome: beyond troponins","volume":"15","author":"A Piccioni","year":"2020","unstructured":"A Piccioni. Novel biomarkers to assess the risk for acute coronary syndrome: beyond troponins. 2020, 15: 1193-1199.","journal-title":"Intern Emerg Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/ejhf.1478","article-title":"Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance","volume":"21","author":"FH Verbrugge","year":"2019","unstructured":"FH Verbrugge. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance. 2019, 21: 1415-1422.","journal-title":"Eur J Heart Fail"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s40261-017-0577-1","article-title":"Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study","volume":"37","author":"T Imiela","year":"2017","unstructured":"T Imiela. Acetazolamide as Add-on Diuretic Therapy in Exacerbations of Chronic Heart Failure: a Pilot Study. 2017, 37: 1175-1181.","journal-title":"Clin Drug Investig"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70014-6","author":"","unstructured":"","journal-title":"null"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1089\/ham.2011.1084","article-title":"Reappraisal of acetazolamide for the prevention of acute mountain sickness: a systematic review and meta-analysis","volume":"13","author":"B Kayser","year":"2012","unstructured":"B Kayser. Reappraisal of acetazolamide for the prevention of acute mountain sickness: a systematic review and meta-analysis. 2012, 13: 82-92.","journal-title":"High Alt Med Biol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.amjms.2020.12.022","article-title":"Efficacy of Acetazolamide for the Prophylaxis of Acute Mountain Sickness: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Clinical Trials","volume":"361","author":"D Gao","year":"2021","unstructured":"D Gao. Efficacy of Acetazolamide for the Prophylaxis of Acute Mountain Sickness: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Clinical Trials. 2021, 361: 635-645.","journal-title":"Am J Med Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e706","DOI":"10.1016\/j.amjmed.2020.05.003","article-title":"A Randomized Controlled Trial of the Lowest Effective Dose of Acetazolamide for Acute Mountain Sickness Prevention","volume":"133","author":"GS Lipman","year":"2020","unstructured":"GS Lipman. A Randomized Controlled Trial of the Lowest Effective Dose of Acetazolamide for Acute Mountain Sickness Prevention. 2020, 133: e706-e715.","journal-title":"Am J Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.wem.2018.09.002","article-title":"Reduced Acetazolamide Dosing in Countering Altitude Illness: A Comparison of 62","volume":"30","author":"SE McIntosh","year":"2019","unstructured":"SE McIntosh. Reduced Acetazolamide Dosing in Countering Altitude Illness: A Comparison of 62. 2019, 30: 12-21.","journal-title":"5 vs 125 mg (the RADICAL Trial). Wilderness Environ Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.wem.2019.04.006","article-title":"Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Acute Altitude Illness: 2019 Update","volume":"30","author":"AM Luks","year":"2019","unstructured":"AM Luks. Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Acute Altitude Illness: 2019 Update. 2019, 30: S3-S18.","journal-title":"Wilderness Environ Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11143937","author":"","unstructured":"","journal-title":"null"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/medicina58010104","article-title":"Dysbarism: An Overview of an Unusual Medical Emergency","volume":"58","author":"G Savioli","year":"2022","unstructured":"G Savioli. Dysbarism: An Overview of an Unusual Medical Emergency. 2022, 58: 104.","journal-title":"Medicina (Kaunas)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.5960\/dzsm.2020.445","author":"","unstructured":"","journal-title":"null"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"CD009567","DOI":"10.1002\/14651858.CD009567.pub2","article-title":"Interventions for treating acute high altitude illness","volume":"6","author":"D Simancas-Racines","year":"2018","unstructured":"D Simancas-Racines. Interventions for treating acute high altitude illness. 2018, 6: CD009567.","journal-title":"Cochrane database Syst Rev"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/10408369991239286","article-title":"Metabolic alkalosis in the critically ill","volume":"36","author":"NR Webster","year":"1999","unstructured":"NR Webster. Metabolic alkalosis in the critically ill. 1999, 36: 497-510.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3109\/15412550903341448","article-title":"Post-hypercapnic alkalosis is associated with ventilator dependence and increased ICU stay","volume":"6","author":"A Banga","year":"2009","unstructured":"A Banga. Post-hypercapnic alkalosis is associated with ventilator dependence and increased ICU stay. 2009, 6: 437-440.","journal-title":"COPD"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/cc11323","author":"","unstructured":"","journal-title":"null"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/crj.12025","article-title":"Acetazolamide improves oxygenation in patients with respiratory failure and metabolic alkalosis","volume":"7","author":"R Gulsvik","year":"2013","unstructured":"R Gulsvik. Acetazolamide improves oxygenation in patients with respiratory failure and metabolic alkalosis. 2013, 7: 390-396.","journal-title":"Clin Respir J"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1001\/jama.2016.0019","article-title":"Effect of Acetazolamide vs Placebo on Duration of Invasive Mechanical Ventilation Among Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial","volume":"315","author":"C Faisy","year":"2016","unstructured":"C Faisy. Effect of Acetazolamide vs Placebo on Duration of Invasive Mechanical Ventilation Among Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial. 2016, 315: 480-488.","journal-title":"JAMA"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/arm91050034","article-title":"Cardiogenic Pulmonary Edema in Emergency Medicine","volume":"91","author":"C Zanza","year":"2023","unstructured":"C Zanza. Cardiogenic Pulmonary Edema in Emergency Medicine. 2023, 91: 445-463.","journal-title":"Adv Respir Med"},{"key":"ref32","first-page":"37","article-title":"Effect of acetazolamide on post-NIV metabolic alkalosis in acute exacerbated COPD patients","volume":"20","author":"V Fontana","year":"2016","unstructured":"V Fontana. Effect of acetazolamide on post-NIV metabolic alkalosis in acute exacerbated COPD patients. 2016, 20: 37-43.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jocn.2021.11.029","article-title":"Idiopathic intracranial hypertension: Pathophysiology, diagnosis and management","volume":"95","author":"MTM Wang","year":"2022","unstructured":"MTM Wang. Idiopathic intracranial hypertension: Pathophysiology, diagnosis and management. 2022, 95: 172-179.","journal-title":"J Clin Neurosci Off J Neurosurg Soc Australas"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1212\/WNL.0000000000001896","article-title":"Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension","volume":"85","author":"M Wall","year":"2015","unstructured":"M Wall. Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension. 2015, 85: 799-805.","journal-title":"Neurology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11910-020-1026-8","article-title":"Fulminant Idiopathic Intracranial Hypertension","volume":"20","author":"MA Bouffard","year":"2020","unstructured":"MA Bouffard. Fulminant Idiopathic Intracranial Hypertension. 2020, 20: 8.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1586\/14737175.2015.1066675","article-title":"Acetazolamide for the treatment of idiopathic intracranial hypertension","volume":"15","author":"CT Supuran","year":"2015","unstructured":"CT Supuran. Acetazolamide for the treatment of idiopathic intracranial hypertension. 2015, 15: 851-856.","journal-title":"Expert Rev Neurother"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1001\/jama.2014.3312","article-title":"Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial","volume":"311","author":"M Wall","year":"2014","unstructured":"M Wall. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. 2014, 311: 1641-1651.","journal-title":"JAMA"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1212\/01.wnl.0000251312.19452.ec","article-title":"Fulminant idiopathic intracranial hypertension","volume":"68","author":"M Thambisetty","year":"2007","unstructured":"M Thambisetty. Fulminant idiopathic intracranial hypertension. 2007, 68: 229-232.","journal-title":"Neurology"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1056\/NEJMicm1712742","article-title":"Acute Angle-Closure Glaucoma","volume":"378","author":"H Pohl","year":"2018","unstructured":"H Pohl. Acute Angle-Closure Glaucoma. 2018, 378: e14.","journal-title":"N Engl J Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.mcna.2021.01.004","article-title":"Glaucoma","volume":"105","author":"JM Kang","year":"2021","unstructured":"JM Kang. Glaucoma. 2021, 105: 493-510.","journal-title":"Med Clin North Am"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/S0140-6736(23)01289-8","article-title":"Glaucoma: now and beyond","volume":"402","author":"H Jayaram","year":"2023","unstructured":"H Jayaram. Glaucoma: now and beyond. 2023, 402: 1788-1801.","journal-title":"Lancet (London, England)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2021.1931123","author":"","unstructured":"","journal-title":"null"},{"issue":"12","key":"ref43","doi-asserted-by":"publisher","first-page":"C174","DOI":"10.12968\/hmed.2019.80.12.C174","article-title":"Acute angle closure glaucoma","volume":"80","author":"BC Flores-S\u00e1nchez","year":"2019","unstructured":"BC Flores-S\u00e1nchez. Acute angle closure glaucoma. 2019, 80(12): C174-C179.","journal-title":"Br J Hosp Med (Lond)."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5005\/jp-journals-10008-1100","article-title":"Drug-induced Angle-Closure Glaucoma","volume":"6","author":"AK Khurana","year":"2012","unstructured":"AK Khurana. Drug-induced Angle-Closure Glaucoma. 2012, 6: 6-8.","journal-title":"J Curr glaucoma Pract"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"104","DOI":"10.5005\/jp-journals-10078-1261","article-title":"Drug-induced Acute Angle-closure Glaucoma: A Review","volume":"13","author":"MC Yang","year":"2019","unstructured":"MC Yang. Drug-induced Acute Angle-closure Glaucoma: A Review. 2019, 13: 104-109.","journal-title":"J Curr glaucoma Pract"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/WCO.0000000000000769","article-title":"Vertigo and dizziness in the emergency room","volume":"33","author":"A Zwergal","year":"2020","unstructured":"A Zwergal. Vertigo and dizziness in the emergency room. 2020, 33: 117-125.","journal-title":"Curr Opin Neurol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1177\/0194599816630733","article-title":"A Systematic Review of Diuretics in the Medical Management of M\u00e9ni\u00e8re\u2019s Disease","volume":"154","author":"MG Crowson","year":"2016","unstructured":"MG Crowson. A Systematic Review of Diuretics in the Medical Management of M\u00e9ni\u00e8re\u2019s Disease. 2016, 154: 824-834.","journal-title":"Otolaryngol neck Surg Off J Am Acad Otolaryngol Neck Surg"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.bmc.2016.01.012","article-title":"Sulfamide derivatives with selective carbonic anhydrase VII inhibitory action","volume":"24","author":"ML Villalba","year":"2016","unstructured":"ML Villalba. Sulfamide derivatives with selective carbonic anhydrase VII inhibitory action. 2016, 24: 894-901.","journal-title":"Bioorg Med Chem"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1113\/JP273394","article-title":"Bicarbonate sensing in mouse cortical astrocytes during extracellular acid\/base disturbances","volume":"595","author":"SM Theparambil","year":"2017","unstructured":"SM Theparambil. Bicarbonate sensing in mouse cortical astrocytes during extracellular acid\/base disturbances. 2017, 595: 2569-2585.","journal-title":"J Physiol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1528-1157.1992.tb02337.x","article-title":"Increased pH and inorganic phosphate in temporal seizure foci demonstrated by [31P]MRS","volume":"33","author":"KD Laxer","year":"1992","unstructured":"KD Laxer. Increased pH and inorganic phosphate in temporal seizure foci demonstrated by [31P]MRS. 1992, 33: 618-623.","journal-title":"Epilepsia"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1002\/epi4.12619","author":"","unstructured":"","journal-title":"null"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.otc.2011.06.007","article-title":"Traumatic cerebrospinal fluid leaks","volume":"44","author":"JD Prosser","year":"2011","unstructured":"JD Prosser. Traumatic cerebrospinal fluid leaks. 2011, 44: 857-873.","journal-title":"Otolaryngol Clin North Am"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/WNO.0b013e318299c292","article-title":"Primary spontaneous cerebrospinal fluid leaks and idiopathic intracranial hypertension","volume":"33","author":"MA P\u00e9rez","year":"2013","unstructured":"MA P\u00e9rez. Primary spontaneous cerebrospinal fluid leaks and idiopathic intracranial hypertension. 2013, 33: 330-337.","journal-title":"J neuro-ophthalmology Off J North Am Neuro-Ophthalmology Soc"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/lio2.75","article-title":"Surgical repair of spontaneous cerebrospinal fluid (CSF) leaks: A systematic review","volume":"2","author":"BC Lobo","year":"2017","unstructured":"BC Lobo. Surgical repair of spontaneous cerebrospinal fluid (CSF) leaks: A systematic review. 2017, 2: 215-224.","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S1474-4422(21)00423-3","article-title":"Spontaneous intracranial hypotension: searching for the CSF leak","volume":"21","author":"T Dobrocky","year":"2022","unstructured":"T Dobrocky. Spontaneous intracranial hypotension: searching for the CSF leak. 2022, 21: 369-380.","journal-title":"Lancet Neurol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1056\/NEJMra2101561","article-title":"Spontaneous Intracranial Hypotension","volume":"385","author":"WI Schievink","year":"2021","unstructured":"WI Schievink. Spontaneous Intracranial Hypotension. 2021, 385: 2173-2178.","journal-title":"N Engl J Med"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.otc.2011.06.018","article-title":"Spontaneous CSF Leaks","volume":"44","author":"EW Wang","year":"2011","unstructured":"EW Wang. Spontaneous CSF Leaks. 2011, 44: 845-856.","journal-title":"Otolaryngol Clin North Am"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/alr.22245","article-title":"Preoperative management of spontaneous cerebrospinal fluid rhinorrhea with acetazolamide","volume":"9","author":"AM Tilak","year":"2019","unstructured":"AM Tilak. Preoperative management of spontaneous cerebrospinal fluid rhinorrhea with acetazolamide. 2019, 9: 265-269.","journal-title":"Int Forum Allergy Rhinol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s12070-019-01728-5","article-title":"Approach to Management of Cerebrospinal Fluid Rhinorrhea: Institutional Based Protocol","volume":"74","author":"N Ramakrishnan","year":"2022","unstructured":"N Ramakrishnan. Approach to Management of Cerebrospinal Fluid Rhinorrhea: Institutional Based Protocol. 2022, 74: 737-744.","journal-title":"Indian J Otolaryngol head neck Surg Off Publ Assoc Otolaryngol India"},{"key":"ref60","first-page":"467","article-title":"Analysing the effect of early acetazolamide administration on patients with a high risk of permanent cerebrospinal fluid leakage","volume":"51","author":"S Abrishamkar","year":"2013","unstructured":"S Abrishamkar. Analysing the effect of early acetazolamide administration on patients with a high risk of permanent cerebrospinal fluid leakage. 2013, 51: 467-471.","journal-title":"Acta Med Iran"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"e24825","DOI":"10.7759\/cureus.24825","article-title":"Evaluating the Effectiveness of Pretreatment With Intravenous Fluid in Reducing the Risk of Developing Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis","volume":"14","author":"HA Zaki","year":"2022","unstructured":"HA Zaki. Evaluating the Effectiveness of Pretreatment With Intravenous Fluid in Reducing the Risk of Developing Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis. 2022, 14: e24825.","journal-title":"Cureus"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s11255-008-9520-y","article-title":"A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: a randomized, double-blind trial","volume":"41","author":"M Pakfetrat","year":"2009","unstructured":"M Pakfetrat. A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: a randomized, double-blind trial. 2009, 41: 629-634.","journal-title":"Int Urol Nephrol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00246-005-1132-z","article-title":"Acetazolamide for prevention of contrast-induced nephropathy: a new use for an old drug","volume":"27","author":"F Assadi","year":"2006","unstructured":"F Assadi. Acetazolamide for prevention of contrast-induced nephropathy: a new use for an old drug. 2006, 27: 238-242.","journal-title":"Pediatr Cardiol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/BF00689708","article-title":"Acetazolamide for alkalinisation of urine in patients receiving high-dose methotrexate","volume":"28","author":"J Shamash","year":"1991","unstructured":"J Shamash. Acetazolamide for alkalinisation of urine in patients receiving high-dose methotrexate. 1991, 28: 150-151.","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"8065","DOI":"10.2147\/CMAR.S190084","article-title":"A prospective study on urine alkalization with an oral regimen consisting of sodium bicarbonate and acetazolamide in patients receiving high-dose methotrexate","volume":"11","author":"DR Reed","year":"2019","unstructured":"DR Reed. A prospective study on urine alkalization with an oral regimen consisting of sodium bicarbonate and acetazolamide in patients receiving high-dose methotrexate. 2019, 11: 8065-8072.","journal-title":"Cancer Manag Res"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/imj.14468","article-title":"Addition of low dose acetazolamide as an adjunct in patients undergoing high dose methotrexate is safe and beneficial","volume":"50","author":"M Ku","year":"2020","unstructured":"M Ku. Addition of low dose acetazolamide as an adjunct in patients undergoing high dose methotrexate is safe and beneficial. 2020, 50: 357-362.","journal-title":"Intern Med J"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1016\/S2352-3026(16)00036-3","article-title":"Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial","volume":"3","author":"AJM Ferreri","year":"2016","unstructured":"AJM Ferreri. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. 2016, 3: e217-e227.","journal-title":"Lancet Haematol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1177\/1078155211426913","article-title":"Reduced time for urinary alkalinization before high-dose methotrexate with preadmission oral bicarbonate","volume":"18","author":"PE Kintzel","year":"2012","unstructured":"PE Kintzel. Reduced time for urinary alkalinization before high-dose methotrexate with preadmission oral bicarbonate. 2012, 18: 239-244.","journal-title":"J Oncol Pharm Pract Off Publ Int Soc Oncol Pharm Pract"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/1078155220908946","article-title":"Evaluation of methotrexate clearance with an enteral urine alkalinization protocol for patients receiving high-dose methotrexate","volume":"27","author":"E Kramer","year":"2021","unstructured":"E Kramer. Evaluation of methotrexate clearance with an enteral urine alkalinization protocol for patients receiving high-dose methotrexate. 2021, 27: 26-32.","journal-title":"J Oncol Pharm Pract Off Publ Int Soc Oncol Pharm Pract"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-023-01850-2","author":"","unstructured":"","journal-title":"null"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2020-000557","author":"","unstructured":"","journal-title":"null"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1086\/342299","article-title":"A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis","volume":"35","author":"PN Newton","year":"2002","unstructured":"PN Newton. A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis. 2002, 35: 769-772.","journal-title":"Clin Infect Dis an Off Publ Infect Dis Soc Am"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.jemermed.2020.01.019","article-title":"Acetazolamide Causes Worsening Acidosis in Uncompensated COPD Exacerbations: Increased Awareness Needed for Patient Safety","volume":"58","author":"JL Cole","year":"2020","unstructured":"JL Cole. Acetazolamide Causes Worsening Acidosis in Uncompensated COPD Exacerbations: Increased Awareness Needed for Patient Safety. 2020, 58: 953-958.","journal-title":"J Emerg Med"},{"key":"ref74","first-page":"28","article-title":"Effects of low-dose acetazolamide on exercise performance in simulated altitude","volume":"9","author":"E Elisabeth","year":"2017","unstructured":"E Elisabeth. Effects of low-dose acetazolamide on exercise performance in simulated altitude. 2017, 9: 28-34.","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.resp.2012.08.023","article-title":"Effect of acetazolamide on respiratory muscle fatigue in humans","volume":"185","author":"JU Gonzales","year":"2013","unstructured":"JU Gonzales. Effect of acetazolamide on respiratory muscle fatigue in humans. 2013, 185: 386-392.","journal-title":"Respir Physiol Neurobiol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1159\/000350939","article-title":"Cutaneous adverse drug reaction to oral acetazolamide and skin tests","volume":"226","author":"M Jachiet","year":"2013","unstructured":"M Jachiet. Cutaneous adverse drug reaction to oral acetazolamide and skin tests. 2013, 226: 347-352.","journal-title":"Dermatology"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1056\/NEJMoa022963","article-title":"Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics","volume":"349","author":"BL Strom","year":"2003","unstructured":"BL Strom. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. 2003, 349: 1628-1635.","journal-title":"N Engl J Med"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1016\/j.jaip.2019.05.034","article-title":"Sulfonamide Hypersensitivity: Fact and Fiction","volume":"7","author":"DA Khan","year":"2019","unstructured":"DA Khan. Sulfonamide Hypersensitivity: Fact and Fiction. 2019, 7: 2116-2123.","journal-title":"J allergy Clin Immunol Pract"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/archneurol.2011.2723","article-title":"Use of acetazolamide in sulfonamide-allergic patients with neurologic channelopathies","volume":"69","author":"D Platt","year":"2012","unstructured":"D Platt. Use of acetazolamide in sulfonamide-allergic patients with neurologic channelopathies. 2012, 69: 527-529.","journal-title":"Arch Neurol"}],"container-title":["Journal of Geriatric Cardiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T08:51:07Z","timestamp":1735807867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciopen.com\/article\/10.26599\/1671-5411.2024.11.005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":78,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"URL":"https:\/\/doi.org\/10.26599\/1671-5411.2024.11.005","relation":{},"ISSN":["1671-5411"],"issn-type":[{"value":"1671-5411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}